|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Theravance Biopharma (NASDAQ: TBPH) through any online brokerage.
The latest price target for Theravance Biopharma (NASDAQ: TBPH) was reported by Morgan Stanley on September 16, 2021. The analyst firm set a price target for 10.00 expecting TBPH to rise to within 12 months (a possible 42.45% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Theravance Biopharma (NASDAQ: TBPH) is $7.02 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Theravance Biopharma.
There is no upcoming split for Theravance Biopharma.
Theravance Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.